Alondra Albarado-Ibañez, R. E. Arroyo-Carmona, D. Bernabé-Sánchez, Marissa Limón-Cantú, Benjamín López-Silva, Martha Lucía Ita-Amador, J. Torres-Jácome
{"title":"心率变异性作为代谢性疾病预后的生物标志物","authors":"Alondra Albarado-Ibañez, R. E. Arroyo-Carmona, D. Bernabé-Sánchez, Marissa Limón-Cantú, Benjamín López-Silva, Martha Lucía Ita-Amador, J. Torres-Jácome","doi":"10.5772/intechopen.88766","DOIUrl":null,"url":null,"abstract":"Lifestyle emerging diseases like obesity, metabolic syndrome (MeS), and diabetes mellitus are considered high-risk factors for lethal arrhythmias and side effects. A Poincaré plot is constructed with the time series of RR and PP electrocardiogram (ECG) intervals, using two stages: the new phase and the old phase. We proposed this diagram of two dimensions, a way to quantify and observe the regularity of events in space and time. Therefore, the heart rate variability (HRV) can be used as a biomarker for early prognostic and diagnostic of several metabolic diseases; additionally, this biomarker is obtained by a noninvasive tool like the electrocardiogram.","PeriodicalId":382562,"journal":{"name":"Autonomic Nervous System Monitoring - Heart Rate Variability","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Heart Rate Variability as Biomarker for Prognostic of Metabolic Disease\",\"authors\":\"Alondra Albarado-Ibañez, R. E. Arroyo-Carmona, D. Bernabé-Sánchez, Marissa Limón-Cantú, Benjamín López-Silva, Martha Lucía Ita-Amador, J. Torres-Jácome\",\"doi\":\"10.5772/intechopen.88766\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Lifestyle emerging diseases like obesity, metabolic syndrome (MeS), and diabetes mellitus are considered high-risk factors for lethal arrhythmias and side effects. A Poincaré plot is constructed with the time series of RR and PP electrocardiogram (ECG) intervals, using two stages: the new phase and the old phase. We proposed this diagram of two dimensions, a way to quantify and observe the regularity of events in space and time. Therefore, the heart rate variability (HRV) can be used as a biomarker for early prognostic and diagnostic of several metabolic diseases; additionally, this biomarker is obtained by a noninvasive tool like the electrocardiogram.\",\"PeriodicalId\":382562,\"journal\":{\"name\":\"Autonomic Nervous System Monitoring - Heart Rate Variability\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-09-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Autonomic Nervous System Monitoring - Heart Rate Variability\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5772/intechopen.88766\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Autonomic Nervous System Monitoring - Heart Rate Variability","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5772/intechopen.88766","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Heart Rate Variability as Biomarker for Prognostic of Metabolic Disease
Lifestyle emerging diseases like obesity, metabolic syndrome (MeS), and diabetes mellitus are considered high-risk factors for lethal arrhythmias and side effects. A Poincaré plot is constructed with the time series of RR and PP electrocardiogram (ECG) intervals, using two stages: the new phase and the old phase. We proposed this diagram of two dimensions, a way to quantify and observe the regularity of events in space and time. Therefore, the heart rate variability (HRV) can be used as a biomarker for early prognostic and diagnostic of several metabolic diseases; additionally, this biomarker is obtained by a noninvasive tool like the electrocardiogram.